The Market for Prescription Generic Drugs

Attention: There is an updated edition available for this report.
 
   Single User - $2,112


Loading...
Published Apr 1, 2000 | 268 Pages | Pub ID: KLI20

Now 35% off original sale price of $3250
This report covers the generic drugs industry in the United States and presents all major therapeutic categories for generic drugs between 1995 and 2004. The report analyzes the issues affecting the market, including an assessment of the FDA relationship with the generics industry, generic drug development and performance of the FDA in approving prescription generic drugs. It also identifies existing and probable generic drug strategies pursued by leading generic companies to capture market share and allay brand name interference. Profiles of leading generic drug company participants such as Barr Laboratories, Mylan Pharmaceuticals and Teva Pharmaceuticals is also provided.
    Chapter One: Executive Summary
    Introduction
    Scope And Methodology
    Size And Growth Of The Market
    Trends Affecting The Market
    Industry Structure And Leading Competitors
    The Consumer

    Chapter Two: Introduction
    Overview
    Description
    Research, Development, And U.S. Marketing Approval
    History Of Generic Drugs
    Growth Of Generic Drugs In The United States
    FDA Regulation

    Chapter Three: Products, Markets, And Competitors
    Introduction
    Allergy And Respiratory Drugs

      Product Categories
      • Bronchodilators And Corticosteroids
      • Antihistamines And Decongestants
      • Cough Preparations
      Product News
      Market Size And Forecast
      Competitor Analysis
    Analgesics, Nonsteroidal Anti-Inflammatory Drugs, And Antirheumatic Drugs
      Product Categories
      • Analgesics
      • Nsaids
      • Antirheumatics
      Product News
      Market Size And Forecast
      Competitor Analysis
    Anesthesia Drugs
      Product Categories
      • General
      • Local/Topical
      • Regional
      Product News
      Market Size And Forecast
      Competitor Analysis
    Anti-Infectives
      Product Categories
      • Systemic Anti-Infectives
      • Topical Anti-Infectives
      Product News
      Market Size And Forecast
      Competitor Analysis
    Prescription Generic Cancer Drugs
      Product Categories
      • Chemotherapeutic Agents
      • Chemotherapeutic Adjuvants
      Product News
      Market Size And Forecast
      Competitor Analysis
    Cardiovascular Drugs
      Product Categories
      • Angina And Arrythmia Agents
      • Beta Blockers And Ace Inhibitors
      • Calcium Channel Blockers
      • Diuretics
      • Vasodilators, Vasopressors, And Anticoagulants
      Product News
      Market Size And Forecast
      Competitor Analysis
    Central Nervous System And Psychotherapeutic Drugs
      Product Categories
      • Antidepressants, Stimulants, And Antipsychotics
      • Anticonvulsants, Antispasmodics, And Muscle Relaxants
      • Sedatives/Hypnotics, Tranquilizers, And Antianxiety Agents
      Product News
      Market Size And Forecast
      Competitor Analysis
    Gastrointestinal Drugs
      Product Categories
      • Antidiarrheals
      • Antinauseants
      • Antispasmodics
      • Antiulcer
      • Digestants
      Product News
      Market Size And Forecast
      Competitor Analysis
    Hormonal Drugs
      Product Categories
      • Reproductive And Contraceptive Drugs
      • Steroids
      • Diabetes Drugs
      • Thyroid Drugs
      Product News
      Market Size And Forecast
      Competitor Analysis
    Ophthalmic Drugs
      Product Categories
      • Ophthalmic Anti-Infectives
      • Ophthalmic Anti-Inflammatories And Mast Cell Inhibitors
      • Glaucoma Agents
      Product News
      Market Size And Forecast
      Competitor Analysis
    Market Summary
      Market Size And Forecast
      First-To-Market Drugs Of 1998
      Patent Expirations

    Chapter Four: Issues And Trends
    Introduction
    Bioequivalency
    Therapeutic Labeling Of Generic Drugs
    Brand-Name Monopolies
    FDA Allocation Of Resources
    Anda Review
    Generic Biologics And Biotechnology Products
    Legal And Legislative Issues
    Managed Care
    Medicare Generic Drug Preference
    Mergers And Acquisitions
    Brand-Name Company Participation
    Market Channels
    Pediatric Studies Rule
    Industry Coalition
    The Elderly
    Patent Issues
    Pricing Issues
    State Substitution And Narrow Therapeutic Index

    Chapter Five: Prescription Generic Drug Strategies
    Introduction
    Mergers And Acquisitions
    Advertising
    Branded Products
    Competitive Pricing
    Continuous Anda Pipeline
    Cost-Effective Production
    First To Market
    Managed Care And Wholesaler Marketing
    Identification Of Markets
    Breadth Of Product Line
    Distribution
    Retail Partnerships

    Chapter Six: Competitor Profiles
    Industry Structure And Participants
    Alpharma, Inc.

      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Apothecon
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Barr Laboratories, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Bausch & Lomb, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Dey Laboratories, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Duramed Pharmaceuticals, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Geneva Pharmaceuticals, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Global Pharmaceutical Corporation
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Mylan Laboratories, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Roxane Laboratories, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Schein Pharmaceutical, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Sicor, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Teva Pharmaceuticals USA, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Watson Pharmaceuticals, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Zenith Goldline Pharmaceuticals, Inc.
      History And Lines Of Business
      Generic Drug Products And Markets
      Financial Information
      Corporate Strategies
    Appendix
    Company Names And Addresses

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.